PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 59 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $356,951 | -2.8% | 115,518 | +41.6% | 0.00% | – |
| Q2 2023 | $367,178 | +204.3% | 81,595 | +285.5% | 0.00% | – |
| Q1 2023 | $120,652 | -5.6% | 21,167 | 0.0% | 0.00% | – |
| Q4 2022 | $127,849 | -8.7% | 21,167 | 0.0% | 0.00% | – |
| Q3 2022 | $140,000 | +27.3% | 21,167 | 0.0% | 0.00% | – |
| Q2 2022 | $110,000 | -84.4% | 21,167 | -79.2% | 0.00% | – |
| Q1 2022 | $703,000 | -47.3% | 101,906 | -4.9% | 0.00% | – |
| Q4 2021 | $1,335,000 | -59.9% | 107,184 | +0.7% | 0.00% | -100.0% |
| Q3 2021 | $3,326,000 | -2.1% | 106,425 | -10.3% | 0.00% | 0.0% |
| Q2 2021 | $3,398,000 | -32.1% | 118,677 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $5,005,000 | -39.2% | 115,499 | +0.4% | 0.00% | -50.0% |
| Q4 2020 | $8,229,000 | – | 115,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
| Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
| Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
| Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
| HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
| Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
| Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
| ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
| FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |